Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

Abstract Details

Longitudinal Assessment of High- and Low-Contrast Visual Acuity in Normally-Sighted Children
Child Neurology and Developmental Neurology
P10 - Poster Session 10 (8:00 AM-9:00 AM)
4-009
Visual acuity (VA) is often used as an outcome measure in clinical and research investigations, although age-related normative contrast data is lacking. We have previously demonstrated in a cross-sectional cohort (ages 5-20 years, grouped by age) that mean monocular and binocular high-contrast visual acuity (HCVA) and monocular low-contrast letter acuity (LCLA) scores increase with age linearly between 5–14 years in normally-sighted youth; however, improvements in acuity scores have not been validated longitudinally in individual children.
To characterize longitudinal visual changes in healthy children.
Children and young adults without neurologic, systemic, or ocular diseases (except refractive error) enrolled in our research program were eligible for longitudinal vision testing. Binocular HCVA and LCLA were assessed at 2 meters using EDTRS and Sloan charts (2.5% and 1.25% contrast). Linear regression with generalized estimating equations to account for repeated observations were used to calculate mean annual visual acuity change.
Among 101 subjects enrolled in the cross-sectional study, 27 subjects returned for longitudinal testing at a mean of 2.78 years after initial testing. For subjects ≥13 years of age, the mean annual change in binocular scores in letters was -0.67 (p=0.01), -0.82 (p=0.04), and -1.58 (p=0.01) for HCVA, LCLA 2.5%, and LCLA 1.25%, respectively. For subjects <13 years, the mean annual change in binocular scores was 2.31 (p=0.008), 1.71 (p=0.003), and 2.03 (p=0.04) for HCVA, LCLA 2.5%, and LCLA 1.25%, respectively. For all levels of contrast, subjects <7 years of age demonstrated the greatest mean annual changes.
While HCVA, LCLA 2.5%, and LCLA 1.25% increase annually in children <13 years, scores are expected to remain constant or slightly decrease thereafter. Given variabilities in normal visual acuity changes across the age span, clinicians should use caution when interpreting treatment response or disease progression based on such measures.
Authors/Disclosures
John Rainer Sollee (Sidney Kimmel Medical College At Thomas Jefferson University)
PRESENTER
Mr. Sollee has nothing to disclose.
Amy Lavery No disclosure on file
Geraldine *Use 388658 Liu An immediate family member of Geraldine Liu has received publishing royalties from a publication relating to health care.
Maxwell Pistilli, PhD Dr. Pistilli has nothing to disclose.
Gui-shuang Ying No disclosure on file
Amy T. Waldman, MD (Children's Hospital of Philadelphia) Dr. Waldman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for SwanBio. An immediate family member of Dr. Waldman has stock in Pfizer. The institution of Dr. Waldman has received research support from Ionis Pharmaceuticals. Dr. Waldman has received publishing royalties from a publication relating to health care.